Publikationen

Is Chemoendocrine Treatment without Alternative?

Greil R. Breast Care (Basel). 2008,3(4):231-235. Epub 2008 Aug 22.

View this publication in the PUBMED database

The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.

Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG Breast Cancer Res Treat. 2009 May,115(2):373-80. doi: 10.1007/s10549-008-0132-0. Epub 2008 Jul 26.

View this publication in the PUBMED database

Fulvestrant (‚Faslodex‘) in heavily pretreated postmenopausal patients with advanced breast cancer: single centre clinical experience from the compassionate use programme.

Mlineritsch B, Psenak O, Mayer P, Moik M, Namberger K, Hauser-Kronberger C, Greil R. Breast Cancer Res Treat. 2007 Nov,106(1):105-12. Epub 2007 Feb 13.

View this publication in the PUBMED database

Systemic application of granulocyte-colony stimulating factor and stem cell factor exacerbates excitotoxic brain injury in newborn mice.

Keller M, Simbruner G, Gorna A, Urbanek M, Tinhofer I, Griesmaier E, Sarkozy G, Schwendimann L, Gressens P. Pediatric Research. 2006 Apr, 59 (4 Pt 1): 549-53.

View this publication in the PUBMED database

Wie sterben wir? Wie schГ¶n ist der Tod? Wie teuer ist der Tod? – Die Palliativmedizin im Spannungsfeld der Ressourcenallokation

Greil, R, In: Fischer, M, Zänker, KS, editors(s). Medizin- und Bioethik. (ISBN: 978-3-631-54744-1 )

A role of TRAIL in killing osteoblasts by myeloma cells.

Tinhofer I, Biedermann R, Krismer M, Crazzolara R, Greil R. FASEB J. 2006 Apr,20(6):759-61. Epub 2006 Jan 25.

View this publication in the PUBMED database

Lymphoproliferative Erkrankungen.

Greil, R, 2006.

A role of TRAIL in killing osteoblasts by myeloma cells

Tinhofer, I, Biedermann, R, Krismer, M, Crazzolara, R, Greil, R FASEB J. 2006 Apr,20(6):759-61. Epub 2006 Jan 25.

The still long and winding road to neoadjuvant sytemic therapy as the standard of care in breast cancer

Greil, R BREAST CARE. 2006, 1(6): 352-357.

Adjuvant treatment with trastuzumab in clinical practice outside clinical studies

Senn, HJ, Thurlimann, B, von Minckwitz, G, Herrmann, R, Jakesz, R, Gnant, M, Greil, R BREAST CARE. 2006, 1(2): 96-101.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.